Promoting informed approaches in precision oncology and clinical trial participation for Black patients with cancer: Community-engaged development and pilot testing of a digital intervention.

An, Jinghua; Ferrante, Jeanne M; Macenat, Myneka; Ganesan, Shridar; Hudson, Shawna V; Omene, Coral; Garcia, Harold; Kinney, Anita Y

An, Jinghua; Ferrante, Jeanne M; Macenat, Myneka; Ganesan, Shridar; Hudson, Shawna V; Omene, Coral; Garcia, Harold; Kinney, Anita Y.

Afiliación

An J; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
Ferrante JM; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
Macenat M; Rutgers Robert Wood Johnson Medical School, The State University of New Jersey, New Brunswick, New Jersey, USA.
Ganesan S; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
Hudson SV; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
Omene C; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
Garcia H; Rutgers Robert Wood Johnson Medical School, The State University of New Jersey, New Brunswick, New Jersey, USA.
Kinney AY; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.

Cancer ; 2023 Oct 13.

Article en En | MEDLINE | ID: mdl-37837177

Palabras clave

chatbot; clinical trial participation; decision-making; digital intervention; immunotherapy; precision medicine; targeted therapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancer Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google